NZSE - Delayed Quote NZD

Greenfern Industries Limited (GFI.NZ)

Compare
0.0200 +0.0010 (+5.26%)
As of 10:00 am NZDT. Market open.
Loading Chart for GFI.NZ
DELL
  • Previous close 0.0190
  • Open 0.0200
  • Bid 0.0200 x --
  • Ask 0.0220 x --
  • Day's range 0.0200 - 0.0200
  • 52-week range 0.0150 - 0.0630
  • Volume 1,952
  • Avg. Volume 164,945
  • Market cap (intra-day) 2.381M
  • Beta (5Y monthly) --
  • PE ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings date --
  • Forward dividend & yield --
  • Ex-dividend date --
  • 1y target est --

Greenfern Industries Limited operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand. It operates in the medicinal cannabis, industrial hemp, hemp food, and body care spaces. The company was incorporated in 2018 and is headquartered in Auckland, New Zealand.

gfi.nz

--

Full-time employees

--

Fiscal year ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Related news

View more

Performance overview: GFI.NZ

Trailing total returns as of 31/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD return

GFI.NZ
64.29%
S&P/NZX 50 INDEX GROSS ( GROSS
6.83%

1-year return

GFI.NZ
56.52%
S&P/NZX 50 INDEX GROSS ( GROSS
16.89%

3-year return

GFI.NZ
92.58%
S&P/NZX 50 INDEX GROSS ( GROSS
4.01%

5-year return

GFI.NZ
93.43%
S&P/NZX 50 INDEX GROSS ( GROSS
0.00%

Compare to: GFI.NZ

Select to analyse similar companies using key performance metrics; select up to four stocks.

Statistics: GFI.NZ

View more

Valuation measures

As of 31/10/2024
  • Market cap

    2.19M

  • Enterprise value

    2.86M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG ratio (5-yr expected)

    --

  • Price/sales (ttm)

    6.52

  • Price/book (mrq)

    1.14

  • Enterprise value/revenue

    8.73

  • Enterprise value/EBITDA

    --

Financial highlights

Profitability and income statement

  • Profit margin

    0.00%

  • Return on assets (ttm)

    --

  • Return on equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net income avi to common (ttm)

    --

  • Diluted EPS (ttm)

    -0.0100

Balance sheet and cash flow

  • Total cash (mrq)

    --

  • Total debt/equity (mrq)

    --

  • Levered free cash flow (ttm)

    --

People also watch